南京医药：关于公司及子公司使用部分暂时闲置募集资金进行现金管理到期赎回并继续进行现金管理的公告

Core Points - Nanjing Pharmaceutical announced the use of 170 million yuan of temporarily idle raised funds to purchase a large corporate time deposit from Minsheng Bank, which matured on August 19, 2025 [2] - The company redeemed the principal of 170 million yuan and earned investment income of 573,800 yuan, which met expectations [2] - The company plans to continue using the same amount of 170 million yuan to purchase another large time deposit from Minsheng Bank with a term of 3 months and an annualized yield of 1.10% [2]